• R-Biopharm AG
Languages
  • Deutsch
  • English
  • Home
  • Services
    • Project management
    • Our laboratory
    • Validation & Registration
    • Manufacturing
    • Commercialization
  • Partnering
    • Companion diagnostics
    • Co-Development programs
  • News
  • Contact
A division of R-Biopharm AG
  • Home
  • Services
    • Project management
    • Our laboratory
    • Validation & Registration
    • Manufacturing
    • Commercialization
  • Partnering
    • Companion diagnostics
    • Co-Development programs
  • News
  • Contact

Archives

Monthly Archive for: "April, 2016"
Home /
 R-Biopharm AG to collaborate with HMNC Brain Health on complementary diagnostic test for optimization of depression treatment

R-Biopharm AG to collaborate with HMNC Brain Health on complementary diagnostic test for optimization of depression treatment

R-Biopharm AG announced today it has entered into a collaboration agreement with HMNC Brain Health in the field of complementary diagnostics. Under this agreement R-Biopharm AG will develop an in [...]

Read More
 R-Biopharm AG and Merck KGaA enter into collaboration on developing and launching Companion Diagnostics

R-Biopharm AG and Merck KGaA enter into collaboration on developing and launching Companion Diagnostics

R-Biopharm AG announced today it has entered into an agreement with Merck KGaA, Darmstadt, Germany to collaborate on developing companion diagnostics. The agreement constitutes the first [...]

Read More

R-Biopharm AG

The leading developer of test solutions for clinical diagnostics and food & feed analysis

Company Information
  • R-Biopharm AG
  • An der Neuen Bergstraße 17
    64297 Darmstadt
  • +49 (0) 61 51 - 81 02-537
  • +49 (0) 61 51 - 81 02-40
  • partnering@r-biopharm.de
  • www.r-biopharm.de
Copyright All Rights Reserved ©
  • Imprint
  • Privacy Policy

Start typing and press Enter to search

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Read moreOk